| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 3192836 | Annals of Allergy, Asthma & Immunology | 2009 | 8 Pages |
Abstract
The test formulation was noninferior to the innovator for the primary outcome of MiniRQLQ score. The secondary efficacy and safety end points also support the interchangeability of the 2 formulations.
Related Topics
Health Sciences
Medicine and Dentistry
Dermatology
Authors
Sriram MRCS, Martyn MRCS(Ed), Brian J. MD,